findmyKOL
Clinical trialNCT02023333CompletedPhase 2Interventional

Regorafenib in Good Performance Status Patients With Newly Diagnosed Metastatic Colorectal Adenocarcinoma

SponsorMemorial Sloan Kettering Cancer CenterEnrollment11Metastatic Colorectal Adenocarcinoma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Memorial Sloan Kettering Cancer Center at Basking Ridge

    Basking Ridge, New Jersey, United States

  • Downstate Medical Center

    Brooklyn, New York, United States

  • Memorial Sloan Kettering Cancer Center at Commack

    Commack, New York, United States

  • Queens Cancer Center of Queens Hospital

    Jamaica, New York, United States

  • Memorial Sloan Kettering Cancer Center

    New York, New York, United States

  • Memorial Sloan Kettering Cancer Center at Mercy Medical Center

    Rockville Centre, New York, United States

  • Memorial Sloan Kettering Cancer Center Sleepy Hollow

    Sleepy Hollow, New York, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
10 Dec 2013
Primary completion
26 Aug 2025
Completion
26 Aug 2025
Last update posted
27 Aug 2025
Registered enrollment
11
Registry id
NCT02023333

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.